IDEAYA Biosciences, Inc (NASDAQ:IDYA) Reclaims Clinical Programs And Prepares Near-Term Data Catalysts
![]() |
Ideaya moves into a decisive data-and-programs phase: regained program rights and multiple near-term clinical updates concentrate catalysts while balance-sheet strength funds execution. |









